| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |